The simple fact is that when you refuse to budge on the institution's basic architecture or pricing, or set a clear performance indicator for time-to-funded access, you concede the two obvious levers for delivering what stakeholders want. It explains these consultation processes.
Like rearranging deck chairs on the Titanic. The ship is still going to sink
May 23, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The risk to patients of this institution getting too close to the sun
May 25, 2026 - - Latest News -
Pharmacy Guild urges immediate funding for pharmacy to vaccinate in response to outbreak
May 24, 2026 - - Latest News -
AusBiotech launches survey in response to Budget’s 'blind spot' on R&D impact
May 24, 2026 - - Australian Biotech -
Like rearranging deck chairs on the Titanic. The ship is still going to sink
May 23, 2026 - - Latest News -
Merck funds Indigenous STEM leaders at Macquarie University
May 22, 2026 - - Latest News -
The sharper language will need to be accompanied by even sharper actions
May 22, 2026 - - Latest News -
Industry chiefs want united front as agreement negotiations get underway
May 22, 2026 - - Latest News
